Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: Does it really matter?

Bone Marrow Transplantation

Volumn 37, Issue 2, 2006, Pages 119-133

  Naeem, N ^a   Reed, M D ^b   Creger, R J ^a   Youngner, S J ^c   Lazarus, Hillard M ^a  

^a Division of Hematology/Oncology   (United States)

^b Div Pulmon and Critical Care Med   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Allogeneic and autologous stem cell transplant; Intensive care unit; Umbilical cord blood

Indexed keywords

RECOMBINANT GROWTH FACTOR;

ACUTE LUNG INJURY; AGE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APACHE; ARTIFICIAL VENTILATION; BLOOD CELL; CELL MOTILITY; DISEASE COURSE; DISEASE SEVERITY; DRUG USE; GRAFT VERSUS HOST REACTION; HUMAN; INFECTION; INTENSIVE CARE; INTENSIVE CARE UNIT; MEDICAL LITERATURE; MEDICAL SPECIALIST; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOMES RESEARCH; PATIENT CARE; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; SEPSIS; SURVIVAL RATE;

AGE FACTORS; DISEASE-FREE SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; MULTICENTER STUDIES; RESEARCH DESIGN; RETROSPECTIVE STUDIES; RISK FACTORS; SELECTION BIAS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 30944461618     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705222     Document Type: Review

References (68)

1. Thomas ED, Lochte Jr HL, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 1957; 257: 491-496.
2. Good RA, Meuwissen HJ, Hong R, Gatti RA. Bone marrow transplantation: correction of immune deficit in lymphopenic immunologic deficiency and correction of an immunologically induced pancytopenia. Trans Assoc Am Physicians 1969; 82: 278-285.
3. Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175-181.
4. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174-1178.
5. Wagner JE, Broxmeyer HE, Byrd RL, Zehnbauer B, Schmeckpeper B, Shah N et al. Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment. Blood 1992; 79: 1874-1881.
6. Torrecilla C, Cortes JL, Chamorro C, Rubio JJ, Galdos P, Dominguez de Villota E. Prognostic assessment of acute complications of bone marrow transplantation requiring intensive therapy. Intensive Care Med 1988; 14: 393-398.
7. Crawford SW, Schwartz DA, Petersen FB, Clark JG. Mechanical ventilation after marrow transplantation. Am Rev Resp Dis 1988; 137: 682-687.
8. Denardo SJ, Oye RK, Bellamy PE. Efficacy of intensive care for bone marrow transplant patients with respiratory failure. Crit Care Med 1989; 17: 4-6.
9. Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG. Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clinic Proc 1992; 67: 117-122.
10. Crawford SW, Petersen FB. Long-term survival from respiratory failure after marrow transplantation for malignancy. Am Rev Resp Dis 1992; 145: 510-514.
11. Paz HL, Crilley P, Weinar M, Brodsky I. Outcome of patients requiring medical ICU admission following bone marrow transplantation. Chest 1993; 104: 527-531.
12. Faber-Langendoen K, Caplan AL, McGlave PB. Survival of adult bone marrow transplant patients receiving mechanical ventilation: A case for restricted use. Bone Marrow Transplant 1993; 12: 501-507.
13. Rubenfeld GD, Crawford SW. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: A case for evidence based guidelines. Ann Intern Med 1996; 125: 625-633.
14. Gordon B, Haire W, Ruby E, Kotulak G, Stephens L, Kessinger A et al. Factors predicting morbidity following hematopoietic stem cell transplantation. Bone Marrow Transplant 1997; 19: 497-501.
15. Hollmig KA, Soehngen D, Leschke M, Kobbe G. Schneider P, Klein RM et al. Long-term survival of recipients of allogeneic bone marrow transplantation after mechanical ventilation. Eur J Med Res 1997; 2: 62-66.
16. Jackson SR, Tweeddale MG, Barnett MJ, Spinelli JJ, Sutherland HJ, Reece DE et al. Admission of bone marrow transplant recipients to the intensive care unit: Outcome, survival and prognostic factors. Bone Marrow Transplant 1998; 21: 697-704.
17. Price KJ, Thall P, Kish SK, Shannon VR, Anderson BS. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Resp Crit Care Med 1998; 158: 876-884.
18. Shorr AF, Moores LK, Edenfield WJ, Christie RJ, Fitzpatrick TM. Mechanical ventilation in hematopoietic stem cell transplantation. Chest 1999; 116: 1012-1018.
19. Kress JP, Christenson J, Pohlman AS, Linkin DR, Hall JB. Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 1999; 160: 1957-1961.
20. Staudinger T, Stoiser B, Müllner M, Locker GJ, Laczika K, Knapp S et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 2000; 28: 1322-1328.
21. Huaringa AJ, Leyva FJ, Giralt SA, Blanco J, Signes-Costa J, Velarde H et al. Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med 2000; 28: 1014-1017.
22. Bach PB, Schrag D, Nierman DM. Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood 2001; 98: 3234-3240.
23. Evison JM, Rickenbacher P, Ritz R, Gratwohl A, Haberthur C, Elsasser S et al. Intensive care unit admission in patients with haematological disease: Incidence, outcome and prognostic factors. Swiss Med Wkly 2001; 131: 681-686.
24. Khassawneh BY, White Jr P, Anaissie EJ, Barlogie B, Hiller FC. Outcome from mechanical ventilation after autologus peripheral blood stem cell transplantation. Chest 2002; 121: 185-188.
25. Scott PH, Morgan TJ, Durrant S, Boots RJ. Survival following mechanical ventilation of recipients of bone marrow transplants and peripheral blood stem cell transplants. Anaesth Intensive Care 2002; 30: 289-294.
26. Afessa B, Tefferi A, Dunn WF, Litzow MR, Peters SG. Intensive care unit support and acute physiology and chronic health evaluation III performance in hematopoietic stem cell transplant recipients. Crit Care Med 2003; 31: 1715-1721.
27. Soubani AO, Kseibi E, Bander JJ, Klein JL, Khanchandani G, Ahmed HP et al. Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest 2004; 126: 1604-1611.
28. Nichols DG, Walker LK, Wingard JR, Bender KS, Bezman M, Zahurak ML et al. Predictors of acute respiratory failure after bone marrow transplantation in children. Crit Care Med 1994; 22: 1485-1491.
29. Todd K, Wiley F, Landaw E, Gajewski J, Bellamy PE, Harrison RE et al. Survival outcome among 54 intubated pediatric bone marrow transplant patients. Crit Care Med 1994; 22: 171-176.
30. Warwick AB, Mertens AC, Ou Shu X, Ramsay NKC, Neglia JP. Outcomes following mechanical ventilation in children undergoing bone marrow transplantation. Bone Marrow Transplant 1998; 22: 787-794.
31. Hayes C, Lush RJ, Cornish JM, Foot AM, Henderson J, Jenkins I et al. The outcome of children requiring admission to an intensive care unit following bone marrow transplantation. Br J Haematol 1998; 102: 666-670.
32. Rossi R, Shemie SD, Calderwood S. Prognosis of pediatric bone marrow transplant recipients requiring mechanical ventilation. Crit Care Med 1999; 27: 1181-1186.
33. Diaz de Heredia C, Moreno A, Olive T, Iglesias J, Ortega JJ. Role of the intensive care unit in children undergoing bone marrow transplantation with life-threatening complications. Bone marrow Transplant 1999; 24: 163-168.
34. Keenan HT, Bratton SL, Martin LD, Crawford SW, Weiss NS. Outcome of children who require mechanical ventilatory support after bone marrow transplantation. Crit Care Med 2000; 28: 830-835.
35. Schenider DT, Lemburg P, Sprock I, Heydig R, Gobel U, Nurnberger W. Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children. Bone Marrow Transplant 2000; 25: 1079-1086.
36. Diaz MA, Vicent MG, Prudencio M, Rodriquez F, Marin C, Serrano A et al. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation. Haematologica 2002; 87: 292-298.
37. Jacobe SJ, Hassan A, Veys P, Mok Q. Outcome of children requiring admission to an intensive care unit after bone marrow transplantation. Crit Care Med 2003; 31: 1299-1305.
38. Lamas A, Otheo E, Ros P, Vazquez JL, Maldonado MS, Munoz A et al. Prognosis of child recipients of hematopoietic stem cell transplantation requiring intensive care. Intensive Care Med 2003; 29: 91-96.
39. Hagen SA, Craig DM, Martin PL, Plumer DD, Gentile MA, Schulman SR et al. Mechanically ventilated pediatric stem cell transplant recipients: effect of cord blood transplant and organ dysfunction on outcome. Pediat Crit Care Med 2003; 4: 206-213.
40. Tomaske M, Bosk A, Eyrich M, Bader P, Neithammer D. Risks of mortality in children admitted to the pediatric intensive care unit after hematopoietic stem cell transplantation. Br J Haematol 2003; 121: 886-891.
41. Cheuk DK, Ha SY, Lee SL, Chan GC, Tsoi NS, Lau YL. Prognostic factors in children requiring admission to an intensive care unit after hematopoietic stem cell transplant. Hematol Oncol 2004; 22: 1-9.
42. Testa T, Nahum MA, Spinelli E, Carbone E, Flocchini GP, Motta G. The 'Will Rogers effect' on stage grading. Ann Ital Chir 1999; 70: 829-830.
43. Azoulay E, Recher C, Alberti C, Soufir L, Leleu G, Le Gall JR et al. Changing use of intensive care for hematological patients: The example of multiple myeloma. Intensive Care Med 1999; 25: 1395-1401.
44. Thiery G, Azoulay E, Darmon M, Ciroldi M, De Miranda S, Levy V et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 2005; 23: 4406-4413.
45. Talmadge JE, Reed E, Ino K, Kessinger A, Kuszynski C, Heimann D et al. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 1997, 19: 161-172.
46. Stem Cell Trialists' Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: An individual patient data meta-analysis of nine randomized trials. J Clin Oncol 2005; 23: 5074-5087.
47. Williams CB, Day SD, Reed MD, Copelan EA, Bechtel T, Leather HL et al. Dose modification protocol using intravenous busulfan (Busulfex) and cyclophosphamide followed by autologous or allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Biol Blood Marrow Transplant 2004; 10: 614-623.
48. Corbacioglu S, Greil J, Peters C, Wulffraat N, Laws HJ, Dilloo D et al. Defibrotide in the treatment of children with veno-occlusive disease (VOD): A retrospective multi-center study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant 2004; 33: 189-195.
49. Richardson PG, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D et al. Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: Response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 2002; 100: 4337-4343.
50. Alamo J, Shahjahan M, Lazarus HM, de Lima M, Giralt SA. Co-morbidity indices in hematopoietic stem cell transplantation: A new report card. Bone Marrow Transplant 2005; 36: 475-479.
51. Brower RG, Mathay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301-1308.
52. Yanik G, Hellerstedt B, Custer J, Hutchinson R, Kwon D, Ferrara JL et al. Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2002; 8: 395-400.
53. Azoulay E, Alberti C, Bornstain C, Leleu G, Moreau D, Recher C et al. Improved survival in cancer patients requiring mechanical ventilatory support: Impact of noninvasive mechanical ventilatory support. Crit Care Med 2001; 29: 519-525.
54. Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M, Reiffers J, Cardinaud JP. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever and acute respiratory failure. N Eng J Med 2001; 344: 481-487.
55. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377.
56. Youngner SJ, Allen M, Montenegro H, Hreha J, Lazarus H. Resolving problems at the intensive care unit/oncology interface. Perspect Biol Med 1988; 31: 299-308.
57. Heney D, Lewis IJ, Lockwood L, Cohen AT, Bailey CC. The intensive care unit in pediatric oncology. Arch Dis Child 1992; 67: 294-298.
58. Sivan Y, Schwartz PH, Schonfeld T, Cohen IJ, Newth CJ. Outcome of oncology patients in the pediatric intensive care unit. Intensive Care Med 1991; 17: 11-15.
59. Meert K, Lieh-Lai M, Samaik I, Sarnaik A. The role of intensive care in managing childhood cancer. Am J Clin Oncol 1991; 14: 379-382.
60. Osborne ML. Physician decisions regarding life support in the intensive care unit. Chest 1992; 101: 217-224.
61. Snider GL. Allocation of intensive care. The physician's role. Am J Respir Crit Care Med 1994; 150: 575-580.
62. Curtis JR, Engelberg RA, Wenrich MD, Nielsen EL, Shannon SE, Treece PD et al. Studying communication about end-of-life care during the ICU family conference: Development of a framework. J Crit Care 2002; 17: 147-160.
63. De Valck C, Van de Woestijne KP. Communication problems on an oncology ward. Patient Educ Couns 1996; 29: 131-136.
64. Gelder MS. Life and death decisions in the intensive care unit. Cancer 1995; 76 (Suppl 10): 2171-2175.
65. Paz HL, Garland A, Weinar M, Crilley P, Brodsky I. Effect of clinical outcomes data on intensive care unit utilization by bone marrow transplant patients. Crit Care Med 1998; 26: 66-70.
66. Le Gall JR, Klar J, Lemeshow S, Saulnier F, Alberti C, Artigas A et al. The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 1996; 276: 802-810.
67. Groeger JS, Lemeshow S, Price K, Nierman DM, White Jr P, Klar J et al. Multicenter outcome study of cancer patients admitted to the intensive care unit: A probability of mortality model. J Clin Oncol 1998; 16: 761-770.
68. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.